A Modular Genetic Approach to Newborn Screening from Spinal Muscular Atrophy to Sickle Cell Disease—Results from Six Years of Genetic Newborn Screening
Genes · 13.11.2024 · 15 (11) · 1467
DOI: 10.3390/genes15111467 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 13.11.2024. Verfasst von Jessica Bzdok und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Operative/Restorative Dentistry, Periodontology and Pedodontics, Ludwig-Maximilians-Universität München, 80336 Munich, Germany. Hauptthemen laut MEDLINE: Neonatal Screening, Anemia, Sickle Cell, Muscular Atrophy, Spinal, Genetic Testing. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Genetic newborn screening (NBS) has already entered the phase of common practice in many countries. In Germany, spinal muscular atrophy (SMA), severe combined immunodeficiency (SCID) and sickle cell disease (SCD) are currently a mandatory part of NBS. Here, we describe the experience of six years of genetic NBS including the prevalence of those three diseases in Germany.
Methods
Samples and nucleic acids were extracted from dried blood spot cards, commonly used for NBS. A qPCR assay was used to detect disease-causing variants for SMA and SCD, and the detection of T-cell receptor excision circles (TRECs) was performed for SCID screening.
Results
The results of the NBS of over 1 million newborns for SMA, approximately 770,000 for SCID and over 410,000 for SCD are discussed in detail. In these newborns, we have identified 121 cases of SMA, 15 cases of SCID and syndrome-based immunodeficiencies and 77 cases of SCD or β-thalassemia.
Conclusions
The flexibility of multiplex qPCR is assessed as an effective tool for incorporating different molecular genetic markers for screening. The processing of dried blood spot (DBS) filter cards for molecular genetic assays and the assays are described in detail; turn-around times and cost estimations are included to give an insight into the processes and discuss further options for optimization. The identified cases are in the range expected for the total number of screened newborns, but present a more exact view on the actual prevalences for Germany.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Operative/Restorative Dentistry, Periodontology and Pedodontics, Ludwig-Maximilians-Universität München, 80336 Munich, Germany.
- Laboratory Labor Becker MVZ eGbR, 81671 Munich, Germany.
- TIB Molbiol Syntheselabor GmbH, 12103 Berlin, Germany.
ORCID-Profile: Jessica Bzdok, Ludwig Czibere, Siegfried Burggraf
Zitieren
APA
Bzdok, J., Czibere, L., Burggraf, S., Pauly, N., Maier, E. M., Röschinger, W., Becker, M., & Durner, J. (2024). A Modular Genetic Approach to Newborn Screening from Spinal Muscular Atrophy to Sickle Cell Disease—Results from Six Years of Genetic Newborn Screening. Genes, 15(11), 1467. https://doi.org/10.3390/genes15111467
Vancouver
Bzdok J, Czibere L, Burggraf S, Pauly N, Maier EM, Röschinger W, et al. A Modular Genetic Approach to Newborn Screening from Spinal Muscular Atrophy to Sickle Cell Disease—Results from Six Years of Genetic Newborn Screening. Genes. 2024;15(11):1467. doi:10.3390/genes15111467
BibTeX
@article{Bzdok2024,
author = {Bzdok, Jessica and Czibere, Ludwig and Burggraf, Siegfried and Pauly, Natalie and Maier, Esther M and Röschinger, Wulf and Becker, Marc and Durner, Jürgen},
title = {A Modular Genetic Approach to Newborn Screening from Spinal Muscular Atrophy to Sickle Cell Disease—Results from Six Years of Genetic Newborn Screening},
journal = {Genes},
year = {2024},
volume = {15},
number = {11},
pages = {1467},
doi = {10.3390/genes15111467}
}
EUVIMED